GIL BASHE ON MEDIKA LIFE

20 People Helping Shape AI’s Future Across the Health Ecosystem – 2026

The thinkers expanding our understanding and the builders turning possibility into better research, decisions and patient care

A patient waiting for a diagnosis and a scientist searching for treatment share something important: time matters. The value of artificial intelligence will ultimately be measured by how well it helps people use that time to understand more, make sound decisions, and advance patient care.

That requires people who can see the health ecosystem from 30,000 feet and those who understand what must happen operationally at 3,000 feet, closer to the decisions that determine whether an idea becomes useful. We need thinkers who challenge our assumptions and builders who confront the realities of clinical evidence, fragmented data, staff capacity and patient needs. Often, the same person brings both perspectives. Leadership connects those views by setting priorities, preparing people and taking responsibility for how technology affects care.

This updated 2026 Medika Life roster recognizes 20 people whose research, writing, teaching and practical work help connect those views. It is an editorial selection, presented alphabetically rather than as a ranking. Their contributions differ, but each offers something worth following as the health ecosystem learns to work with AI.

In Memoriam: John Nosta

This update carries sadness. John Nosta, a friend to many across the health innovation world and a distinctive voice within Medika Life, died on Nov. 2, 2026. His absence is felt in a conversation he helped make more thoughtful, more challenging and more human.

John encouraged people to consider how technology changes the way we think. His book, The Borrowed Mind: Reclaiming Human Thought in the Age of AI, explored the responsibility to preserve judgment and understanding as powerful tools become part of our intellectual lives. He recognized the possibilities of large language models while asking what happens when access to an answer begins to substitute for the work of understanding.

His influence deserves its own place here. As the following 20 people help guide AI’s next chapter, John’s questions remain with us: How can technology expand human potential? How do we remain responsible for our own thinking? Those questions will continue to matter wherever decisions affect another person’s health.

Where Ideas Meet the People Who Can Apply Them

These contributions grow through exchange. HIMSS and ViVE provide platforms where health system leaders, clinicians, technology developers, and investors can examine what AI requires beyond demonstrations. HIMSS highlights organizational readiness, governance, and implementation, while ViVE connects digital health ideas with the people evaluating their use across health systems and payer organizations.

Other gatherings deepen that conversation. At the Digital Health & AI Innovation Summit, Amir Lahav, ScD, helps bring scientific, clinical, and technological perspectives to a shared discussion about the future of health. At the recent CNS Summit, Chairman and Chief Curator Amir Kalali, MD, helped weave AI into the broader conversation about drug development, where better evidence, patient selection and research decisions can influence whether promising science reaches patients.

HLTH, AIMed and NextMed Health also create opportunities to share knowledge across disciplines. Health2Tech, founded by Alex Koshykov, brings that exchange into local, in-person gatherings where health professionals, founders and technology leaders can explore ideas and build working relationships.

The value of these meetings extends into conversations after a session, when someone asks how an idea might work in a particular hospital, research program or clinical trial. That willingness to learn together helps turn individual insight into shared progress.

Leadership and Governance Shape What Happens Next

The health ecosystem needs leaders who can turn enthusiasm for AI into a clear purpose. That begins with deciding which problems deserve attention, involving the people closest to those problems and establishing what evidence would justify introducing a new tool. Clinicians, researchers, patients and operational teams each see consequences that a boardroom discussion can miss. Their participation helps leaders make better choices about where to invest and how to proceed.

Governance gives those choices a structure that people can understand and follow. It identifies who evaluates clinical evidence, protects patient information, examines performance across patient groups and authorizes deployment. It also establishes who monitors a system after introduction, investigates concerns and can pause its use when performance changes. Responsibilities must be clear when developers, health organizations and clinical teams share parts of the work.

The same discipline applies to AI in drug development. Research teams need to understand the provenance of data, assumptions behind an analysis and the evidence supporting a proposed decision. A faster answer has value when people can examine its basis and judge its relevance. Leaders are responsible for creating the conditions in which staff can raise concerns, question output and preserve the rigor on which patient lives depend.

20 People Well-Worth Following

1. Ran Balicer, MD, PhD, MPH: Bringing Prevention Into Everyday Decisions

As chief innovation officer and deputy director general of Clalit Health Services, Ran Balicer works where population health, clinical evidence and AI implementation meet. His perspective is informed by the responsibility to introduce new approaches across a health organization serving millions of people.

Balicer’s contribution is to connect prediction with the care decisions that follow. Identifying risk creates an opportunity; organizing a timely, appropriate response determines its value. His work helps keep prevention and clinical oversight central to the discussion about AI’s future.

2. Regina Barzilay, PhD: Looking Earlier and Searching Further

MIT’s Regina Barzilay has helped develop AI approaches that extend what researchers and clinicians can learn from medical data. Her work includes Mirai for breast cancer risk prediction, Sybil for lung cancer risk prediction and collaborative research applying machine learning to antibiotic discovery.

These contributions connect two important ambitions: recognizing disease risk earlier and expanding the search for treatments. Barzilay’s work gives the health ecosystem concrete research to examine as it considers how AI might change screening and discovery.

3. Harvey Castro, MD, MBA: Helping Clinicians Understand the Tools

Emergency physician Harvey Castro brings the urgency of clinical work to his teaching about AI. His book AI in Emergency Medicine: What All Healthcare Professionals Can Learn from the Artificial Intelligence Revolution introduces clinicians and other readers to the opportunities and limitations of generative AI.

Through writing, speaking and educational resources, Castro makes the subject approachable for people responsible for patient care. That translation matters because meaningful participation in AI decisions requires clinicians who can question a tool, recognize its limits and understand its possible uses.

4. Anthony Chang, MD, MBA, MPH, MS: Connecting Machine Intelligence With Clinical Understanding

Pediatric cardiologist Anthony Chang has made education a central part of advancing AI in medicine. Through AIMed and his book Intelligence-Based Medicine, he helps clinicians understand data science and helps technical audiences appreciate the clinical environment.

His contribution recognizes that implementation requires people who can work across disciplines. A model’s technical performance is one part of the discussion; understanding clinical priorities and human cognition helps determine how that performance might become useful care.

5. Hassan Chaudhury: Helping Innovation Find Its Practical Path

Hassan Chaudhury brings a UK and international perspective shaped by work in health data, entrepreneurship and government. His experience includes serving as the UK government’s global digital health specialist, and his work now includes advising clinical AI company Lyrebird Health.

Chaudhury understands that an innovation must find its way through unfamiliar organizations, expectations and working practices. His contribution is to help connect technological possibility with the people and processes that determine adoption, including the realities of bringing health innovations across borders.

6. Marzyeh Ghassemi, MSc, PhD: Asking Whose Health a Model Represents

Marzyeh Ghassemi leads MIT’s Healthy ML group, which studies how machine learning can support health in ways that are robust, private and fair. Her research examines how technical choices can affect the people represented in health data.

Her work brings a necessary question into the room: does a system perform appropriately for the different people who may depend on it? That question should help shape development and evaluation from the beginning, especially when an overall performance measure can obscure differences among patient groups.

7. John Halamka, MD, MS: Building the Conditions for Wider Use

As president of Mayo Clinic Platform, John Halamka works to connect clinical knowledge, data, and technology development. His work addresses the infrastructure and relationships needed to move useful approaches beyond individual projects.

With Paul Cerrato, he co-authored The Digital Reconstruction of Healthcare: Transitioning from Brick and Mortar to Virtual Care. Across his writing and platform work, Halamka helps leaders consider how organizations must evolve to integrate digital capabilities into care delivery.

8. Isaac “Zak” Kohane, MD, PhD: Bringing Scientific Scrutiny to AI’s Promise

Harvard Medical School’s Isaac “Zak” Kohane connects decades of biomedical informatics research with the questions now facing medicine. As editor-in-chief of NEJM AI, he also helps provide a forum for evaluating the emerging evidence on these technologies.

He co-authored The AI Revolution in Medicine: GPT-4 and Beyond with Peter Lee and Carey Goldberg. His contribution spans both possibility and scrutiny: helping people understand what these systems might do while strengthening the scientific conversation about how they should be evaluated.

9. Daniel Kraft, MD: Seeing What Becomes Possible When Fields Connect

Physician-scientist Daniel Kraft examines the convergence of AI, diagnostics, sensors and other technologies shaping health. As founder and chair of NextMed Health, he brings people from different disciplines together to consider how those capabilities might change prevention and care.

Kraft’s contribution includes helping others see connections that a single specialty may overlook. That broader view is useful when the next practical advance may depend on combining tools, knowledge and experience that usually remain in separate conversations.

10. Tom Lawry: Making AI a Leadership Responsibility

Tom Lawry helps health leaders connect AI strategy with the decisions and organizational changes required for implementation. A former Microsoft health AI executive, he brings experience translating technical developments for boards, executives and clinical leaders.

His books include Hacking Healthcare, Health Care Nation, and AI in Health, the second edition of which was released in October 2026. Across that work, Lawry makes the case for leadership that prepares people and organizations to use AI purposefully, with attention to the human experience of care. His guidance on governance and workforce readiness helps executives connect their ambitions with the responsibilities of implementation.

11. David Lazerson: Making Research More Accessible

David Lazerson, co-founder and CEO of Briya, is addressing the distance between fragmented health data and the evidence researchers need. Briya’s AIRE platform is designed to support clinical and biomedical research through conversational interaction, epidemiological methods and researcher oversight.

Opening a no-cost version in 2026 extended that effort to a broader scientific audience. The importance of this direction lies in who can participate; making analytical capabilities more accessible may enable more researchers to explore useful questions, while scientific judgment remains essential for interpreting the results.

12. Peter Lee, PhD: Connecting AI Research With Medicine’s Questions

Microsoft’s Peter Lee has helped bring the capabilities and limitations of generative AI into public discussion about medicine. He co-authored The AI Revolution in Medicine: GPT-4 and Beyond with Isaac Kohane and Carey Goldberg.

His work also explores AI’s potential role in scientific discovery, including helping researchers develop hypotheses and conduct parts of the research process. That direction raises an important possibility for the health ecosystem: tools that help scientists investigate more effectively, with people continuing to judge the quality and meaning of the work.

13. Fei-Fei Li, PhD: Keeping Human Purpose Within Technical Progress

Stanford computer scientist Fei-Fei Li has helped shape modern AI while advocating for development guided by human needs. As a founding leader of Stanford’s Institute for Human-Centered AI and a co-founder of AI4ALL, she has connected technical research with education and societal responsibility.

Her book The Worlds I See places scientific discovery within a human story. For health leaders, her work offers a wider perspective on decisions that can otherwise become narrowly technical: whose needs guide development, who participates and how progress affects people.

14. Edward Marx, MS: Leading Change Across the Health Organization

Edward Marx brings the experience of a health system technology leader to the practical questions surrounding AI. A former chief information officer at Cleveland Clinic and Texas Health Resources, he has led digital strategy, governance and organizational change in settings where decisions affect both clinical teams and patients.

His books include Healthcare Digital Transformation and Voices of Innovation, an edited collection. That work reflects a central contribution to this roster: helping leaders connect technology with organizational purpose, clear responsibilities and the people expected to use it. As health systems introduce AI, his experience offers a useful perspective on the leadership required to turn investment into sustained improvements in care.

15. Bertalan Meskó, MD, PhD: Preparing People for a Changing Practice

Bertalan Meskó, director of The Medical Futurist Institute, helps readers examine how AI and digital health may change medicine. His writing translates developments into questions that clinicians, patients and health leaders can use to prepare.

A Guide to Artificial Intelligence in Healthcare and The ChatGPT Revolution extend that educational work. Meskó’s contribution is to make the future more understandable, providing people with the language and context to participate in decisions that will influence their work and care.

16. Raviv Pryluk, PhD: Helping Clinical Trials Learn More

Raviv Pryluk, co-founder and CEO of PhaseV, brings AI into the design and analysis of clinical trials. His team applies causal machine learning and adaptive trial approaches to help researchers investigate treatment responses and make more informed development decisions.

The practical questions are consequential: which patients may respond, what existing data can reveal and how might a trial be designed more effectively? Pryluk’s work shows why AI’s role in drug development extends to the decisions that determine how promising treatments are studied.

17. Sangita Reddy: Connecting AI With Access and Health System Leadership

As joint managing director of Apollo Hospitals, Sangita Reddy brings the perspective of a leader who has translated technology into care across a large health organization. Her work connects AI adoption with clinical decision support, preventive health and the practical challenge of reaching people across India.

Apollo’s collaboration with Roche Diagnostics to integrate AI into clinical decision-making includes validating tools within its research settings. Reddy has also highlighted the need for affordable technologies and algorithms suited to Indian populations, drawing on a rural wearable-monitoring pilot in Andhra Pradesh. These efforts bring an essential leadership question into the conversation: how can innovation become useful, accessible care in the places where people live?

18. Suchi Saria, MSc, PhD: Connecting Early Warning With Clinical Response

Johns Hopkins researcher and Bayesian Health founder Suchi Saria works at the intersection of machine learning and clinical decision support. Her contributions include TREWS, an early warning system developed to help identify patients at risk of sepsis.

Her work brings attention to the relationship between prediction and action. An alert must reach the right people and support an appropriate response within a demanding clinical environment. That is part of the work required to translate a technical capability into something useful for a care team.

19. Nigam Shah, MBBS, PhD: Testing AI Against the Work of Care

Nigam Shah, chief data scientist at Stanford Health Care, connects biomedical data science with the operational demands of a health system. His work includes research on deploying ChatEHR, which supports interaction with information in the electronic health record.

Shah’s perspective helps bring the discussion closer to daily use. Health organizations need to understand how clinicians use these systems, what work they support and what happens after deployment. Those observations help ground decisions about where AI can make a useful contribution.

20. Hal Wolf: Helping Health Systems Prepare to Act

As president and CEO of HIMSS, Hal Wolf works across the health ecosystem to advance the use of information and technology. His influence includes helping leaders examine the organizational readiness required to introduce AI responsibly.

Through its maturity models and educational work, HIMSS connects adoption with data governance, workforce preparation and the capacity to implement change. Wolf brings that practical organizational perspective to a conversation that needs sustained attention to what hospitals and health professionals can use effectively. His role underscores why leadership and governance must develop alongside the technology: organizations need the capacity to evaluate, introduce and oversee the tools they choose.

The Future Takes Shape Through People

These 20 people offer different ways to think about the same responsibility: helping knowledge become useful in the service of health. Some develop new methods, some write books that expand understanding and others build the conditions that allow an organization or researcher to act.

Their work invites participation and calls for accountable leadership. Read the research, question the assumptions and bring the experience of patients and health professionals into the discussion. Establish who is responsible for evaluating evidence, monitoring results and acting when something goes wrong. A completed note, a promising prediction or a faster analysis only becomes meaningful when it helps someone make a sound decision and respond with care.

John Nosta would have kept that conversation moving with another question. Honoring his contribution means continuing to think for ourselves, learning from one another and insisting that humanity guides what comes next.

PATIENT ADVISORY

Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Gil Bashe, Medika Life Editor
Gil Bashe, Medika Life Editorhttps://gil-bashe.medium.com/
Health advocate connecting the dots to transform biopharma, digital health and healthcare innovation | Managing Partner, Chair Global Health FINN Partners | MM&M Top 50 Health Influencer | Top 10 Innovation Catalyst. Gil is Medika Life editor-in-chief and an author for the platform’s EcoHealth and Health Opinion and Policy sections. Gil also hosts the HealthcareNOW Radio show Healthunabashed, writes for Health Tech World, and is a member of the BeingWell team on Medium.

GIL BASHE

Editor in Chief, Medika Life

Meet Medika Life’s Editor-in-Chief, working closely with founding editors Robert Turner and Jeff Livingston, MD. Not your usual health industry executive, Gil Bashe has built a distinctive career spanning more than four decades across health policy, biopharma, life sciences, digital health, eco-health, environmental innovation, and venture capital. These experiences have shaped his enduring commitment to give back and advance more humane, effective care. A champion for innovation that sustains lives and improves how care is delivered, Gil’s perspective was forged in both battlefield and boardroom. He began in health as a combat medic in an elite military unit, later serving as a clergyman tending to the ill; a health products industry lobbyist in environmental affairs; CEO of one of the world’s largest integrated health marketing companies; a principal in a private equity backed venture; a Medika Life author and Health Tech World correspondent; and today as Chair, Global Health and Purpose at FINN Partners, a community dedicated to making a meaningful difference. Gil is also the author of the bestselling book on Amazon, "Healing the Sick Care System: Why People Matter," a call to restore human connection, trust, and partnership at the heart of medicine. The book reflects his lifelong advocacy for patient-centered care and the belief that health systems work best when they honor the dignity, voice and lived experience of people.

CONNECT WITH GIL

ON TWITTER

ON LINKEDIN

ON MEDIUM

All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.